Premium Citicoline Raw Material CDP-Choline CAS 987-78-0 with Factory Price

Due to its precise biochemical targets, Citicoline raw material is extensively utilized in three primary domains:

• Neurological Recovery (Stroke & TBI): In clinical settings, Citicoline is recognized for its ability to reduce cerebral infarction volume. By inhibiting the activation of phospholipases and reducing the release of free fatty acids (particularly arachidonic acid) at the lesion site, it mitigates secondary neural damage following ischemic stroke or traumatic brain injury. It facilitates the resynthesis of cardiolipin and sphingomyelin, accelerating the repair of damaged axons.

• Cognitive Enhancement (Memory & Focus): In the nutraceutical sector, Citicoline is a premier nootropic ingredient. It has been shown to increase levels of norepinephrine and dopamine in the central nervous system. For healthy adults, supplementation with 250–500 mg of raw Citicoline daily is associated with improved attention span, psychomotor speed, and episodic memory. It is a frequent component of premium pre-workout and "smart drug" (smart drug) stacks due to its ability to fuel the brain’s energy demands.

• Age-Related Cognitive Decline: The raw material is also used in interventions for vascular cognitive impairment. By promoting neuronal membrane repair, it helps slow the progression of cognitive decline associated with aging, particularly in the domains of executive function and behavioral performance.

• 
  

Citicoline is a highly stable molecule in powder form if stored correctly. It is recommended to store the raw material in tightly sealed, light-resistant containers in a cool, dry environment (below 25°C). Due to its hygroscopic nature, exposure to atmospheric moisture should be minimized during manufacturing. In aqueous solutions, Citicoline is generally stable at pH levels between 4.0 and 9.0. It is compatible with standard excipients such as microcrystalline cellulose, magnesium stearate, and silicon dioxide, making it suitable for tablets, capsules, sachets, and liquid oral solutions. However, formulators should avoid direct combination with strong oxidizing agents.

Citicoline is generally recognized as safe (GRAS) in many jurisdictions for use as a dietary ingredient. The safety profile is excellent, with a low incidence of adverse events (typically mild GI discomfort at high doses >1000 mg/day). No significant drug-drug interactions have been clinically documented, though caution is advised with anticholinergic medications. Globally, it is approved as a prescription drug for stroke recovery in Japan, Europe, and South Korea, while in the United States and much of Asia, it is marketed as a dietary supplement. Manufacturers exporting this raw material must ensure compliance with ISO 22000, GMP, and organic certification requirements if applicable.

As a raw material, Citicoline stands out due to its unmatched dual mechanism of membrane stabilization and neurotransmitter synthesis. Its versatility from acute neurological treatment (hospital setting) to chronic cognitive maintenance (consumer goods) makes it a high-value ingredient for formulators seeking evidence-based solutions for brain health.